![]() |
市场调查报告书
商品编码
1832086
2025 年至 2033 年眼压计市场规模、份额、趋势及预测(按类型、技术、可携性、最终用户和地区)Tonometer Market Size, Share, Trends and Forecast by Type, Technology, Portability, End User, and Region, 2025-2033 |
2024年,全球眼压计市场规模为3.749亿美元。展望未来, IMARC Group预测,到2033年,该市场规模将达到5.558亿美元,2025年至2033年的复合年增长率为4.5%。目前,北美占据市场主导地位,2024年的市占率将超过39.6%。这种主导地位可归因于较高的青光眼盛行率、先进的医疗基础设施、强有力的报销政策以及数位眼压计的广泛应用。研发投入的增加、人口老化以及定期的眼科检查进一步推动了市场成长,确保了疾病的早期发现和治疗。
全球眼压计市场由眼压计技术的进步驱动,包括非接触式和反弹式眼压计,可提高患者的舒适度和诊断准确性。各国政府(尤其是在发展中国家)越来越多地推出视力保健计划,这正在扩大眼压计的可及性。糖尿病相关眼部疾病(例如糖尿病视网膜病变和高眼压症)的发生率上升,使得定期监测眼压成为必要。对人工智慧整合诊断工具的投资不断增加,正在改善早期疾病的检测。新兴经济体医疗基础设施的不断扩大以及专科眼科诊所的日益增多促进了市场的成长。此外,远距医疗和远距眼科筛检服务的激增,使早期和广泛发现眼部疾病成为可能,从而促进了市场扩张。
美国眼压计市场受到强有力的监管框架的推动,该框架确保了产品创新和品质标准,从而采用了经 FDA 批准的先进眼压计设备。年轻族群中近视和远视的盛行率不断上升,增加了对常规眼科检查的需求。眼科设备製造商和研究机构之间的策略合作正在推动技术进步。便携式和手持式眼压计日益普及,支援在家庭医疗保健和门诊环境中使用。扩大预防性眼科保健服务的保险覆盖范围鼓励经常进行筛检。此外,领先的眼科设备製造商的存在和对人工智慧驱动的眼压计解决方案的不断增加的投资正在加速该国市场的成长。例如,2024 年 5 月,Reichert Technologies 在美国推出了 Tono-Vera 眼压计,其采用专利的 ActiView 系统,可自动、可靠地测量眼压 (IOP)。这款手持装置采用回弹眼压计,无需麻醉。它提供快速、准确的读数,堪比戈德曼眼压计,并具有用户友好的设计和蓝牙连接功能。眼科诊断领域的领导者 Reichert 持续创新,推出 Tono-Vera,提升青光眼患者的照护水准。
人工智慧在眼压测量的应用
人工智慧 (AI) 与眼压测量的结合,正在透过提高诊断准确性和患者管理水平,彻底改变眼压 (IOP) 测量方法。 AI 眼压计利用机器学习演算法分析大型资料集,从而能够早期发现青光眼和高眼压症。这些设备可以评估传统方法可能遗漏的眼压细微变化,从而实现更精准的监测。 AI 整合还支援自动资料解读,减少对专家评估的依赖,并增强偏远地区或医疗资源匮乏地区的可及性。此外,AI 眼压计还能进行预测分析,在患者出现严重视力丧失前识别出有青光眼风险的患者。个人化医疗和数位健康解决方案日益受到关注,这推动了 AI 辅助眼压测量的进一步发展,从而改善了患者的治疗效果。例如,2024 年 5 月,Topcon Healthcare 与微软合作,推动 AI 驱动的「眼部医疗」解决方案。他们将利用云端平台透过眼部扫描对全身和神经系统疾病进行预先筛检。 Topcon 的 IDHea 致力于推动 AI 研究,确保资料安全。他们正在投资人工智慧创新者,并使用微软 Azure 进行安全的资料管理。此举旨在透过人工智慧眼科诊断技术,提高医疗保健的可近性、品质和可负担性。
非接触式和便携式眼压计的兴起
非接触式和便携式眼压计的日益普及,透过提高患者的舒适度和便利性,正在塑造市场。非接触式眼压计(气流式眼压计)无需麻醉,从而减少了不适感和交叉污染的风险。这些设备尤其有利于对传统眼压测量技术敏感的儿科和老年患者。例如,尼德克于2023年4月发布了NT-1/1e非接触式眼压计,取消了角膜厚度测量功能,以满足市场需求。 NT-1提供自动眼压测量功能,并具有病患安全功能和语音引导。 NT-1e提供具有3D追踪的手动测量功能。两种型号均采用灵活、节省空间的设计,可提高诊所效率和患者舒适度。同时,手持式和便携式眼压计在家庭护理机构、门诊中心和远距眼科服务中越来越受欢迎,因为它们可以实现远端监控,并减少频繁就诊的需求。眼压测量设备的小型化,结合无线连接和基于云端的资料存储,允许医疗保健提供者和患者之间即时共享资料,从而促进持续的眼压监测和对高危险群的及时干预。
扩展远距眼科和远距眼科保健服务
远距眼科和远距眼科护理解决方案的需求不断增长,对眼压计市场产生了重大影响。随着人们越来越重视便利且经济高效的眼科护理,许多医疗保健提供者正在将眼压计整合到数位健康平台中。透过连网的眼压计设备和远距医疗应用程序,远端眼压测量使眼科医生无需频繁的面对面咨询即可监测患者。这一趋势在农村和服务欠缺地区尤其显着,因为这些地区获得专业眼科护理的机会有限。此外,能够持续监测眼压的可穿戴眼压计的普及正在增强早期疾病的检测能力。例如,2024年3月,美国国家眼科研究所向普渡大学拨款670万美元,开发创新型智慧隐形眼镜眼压计。这些正在申请专利的设备采用「StickTronics」技术,将持续监测眼压 (IOP) 并输送治疗药物,从而辅助治疗青光眼等慢性眼部疾病。除此之外,虚拟眼科检查和人工智慧诊断的转变有望弥补青光眼管理方面的差距,确保及时介入并降低视力受损的风险。
The global tonometer market size was valued at USD 374.9 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 555.8 Million by 2033, exhibiting a CAGR of 4.5% from 2025-2033. North America currently dominates the market, holding a market share of over 39.6% in 2024. This dominance can be attributed to high glaucoma prevalence, advanced healthcare infrastructure, strong reimbursement policies, and widespread adoption of digital tonometers. Increased R&D investments, aging population, and regular eye screenings further drive market growth, ensuring early disease detection and treatment.
The global tonometer market is driven by technological advancements in tonometry, including non-contact and rebound tonometers, which enhance patient comfort and diagnostic accuracy. Increasing government initiatives for vision care programs, especially in developing nations, are expanding accessibility to tonometry. The rise in diabetes-related eye disorders, such as diabetic retinopathy and ocular hypertension, necessitates regular intraocular pressure monitoring. Growing investments in AI-integrated diagnostic tools are improving early disease detection. Expanding healthcare infrastructure in emerging economies and the increasing presence of specialized ophthalmic clinics contribute to market growth. Additionally, the surge in telemedicine and remote eye screening services is fostering market expansion by enabling early and widespread detection of ocular diseases.
The U.S. tonometer market is propelled by a strong regulatory framework ensuring product innovation and quality standards, leading to the adoption of FDA-approved advanced tonometry devices. The increasing prevalence of myopia and hyperopia among younger populations has heightened the demand for routine eye examinations. Strategic collaborations between ophthalmology device manufacturers and research institutions are driving technological enhancements. The rising popularity of portable and handheld tonometers supports use in home healthcare and ambulatory settings. Expanding insurance coverage for preventive eye care services encourages frequent screenings. Furthermore, the presence of leading ophthalmic equipment manufacturers and increasing investment in AI-driven tonometry solutions are accelerating market growth in the country. For instance, in May 2024, Reichert Technologies launched the Tono-Vera tonometer in the US, featuring the patented ActiView system for automated, reliable intraocular pressure (IOP) measurements. This handheld device uses rebound tonometry, eliminating the need for anesthetic. It provides quick, accurate readings, comparable to Goldmann tonometry, with user-friendly design and Bluetooth connectivity. Reichert, a leader in eye care diagnostics, continues its innovation with Tono-Vera, enhancing glaucoma patient care.
Integration of Artificial Intelligence in Tonometry
The incorporation of artificial intelligence (AI) in tonometry is transforming intraocular pressure (IOP) measurement by improving diagnostic accuracy and patient management. AI-powered tonometers utilize machine learning algorithms to analyze large datasets, enabling early detection of glaucoma and ocular hypertension. These devices can assess subtle variations in IOP that might be missed by conventional methods, allowing for more precise monitoring. AI integration also supports automated data interpretation, reducing dependence on specialist evaluations and enhancing accessibility in remote or underserved areas. Additionally, AI-enabled tonometers facilitate predictive analytics, identifying patients at risk for developing glaucoma before significant vision loss occurs. The growing focus on personalized medicine and digital health solutions is driving further advancements in AI-assisted tonometry, improving patient outcomes. For instance, in May 2024, Topcon Healthcare partnered with Microsoft to advance AI-driven "Healthcare from the Eye" solutions. They'll use cloud platforms for pre-screening systemic and neurological diseases via eye scans. Topcon's IDHea fosters AI research, ensuring data security. They're investing in AI innovators and using Microsoft Azure for secure data management. This aims to improve healthcare access, quality, and affordability through AI-powered eye diagnostics.
Rise of Non-Contact and Portable Tonometers
The increasing adoption of non-contact and portable tonometers is shaping the market by offering enhanced patient comfort and convenience. Non-contact tonometers (air-puff tonometers) eliminate the need for anesthesia, reducing discomfort and the risk of cross-contamination. These devices are particularly beneficial for pediatric and geriatric patients who may be sensitive to traditional tonometry techniques. For instance, in April 2023, Nidek released the NT-1/1e non-contact tonometers, omitting pachymetry to meet market needs. The NT-1 offers automated IOP measurements with patient safety features and voice guidance. The NT-1e provides manual measurement with 3D tracking. Both models feature a flexible, space-saving design for improved clinic efficiency and patient comfort. In parallel, handheld and portable tonometers are gaining popularity in home care settings, ambulatory centers, and teleophthalmology services, enabling remote monitoring and reducing the need for frequent clinical visits. The miniaturization of tonometry devices, combined with wireless connectivity and cloud-based data storage, allows real-time data sharing between healthcare providers and patients, facilitating continuous IOP monitoring and timely intervention in high-risk individuals.
Expansion of Teleophthalmology and Remote Eye Care Services
The rising demand for teleophthalmology and remote eye care solutions is significantly influencing the tonometer market. With increasing emphasis on accessible and cost-effective eye care, many healthcare providers are integrating tonometry into digital health platforms. Remote IOP measurement, enabled by connected tonometry devices and telemedicine applications, allows ophthalmologists to monitor patients without requiring frequent in-person consultations. This trend is particularly impactful in rural and underserved regions, where access to specialized ophthalmic care is limited. Additionally, the expansion of wearable tonometers capable of continuous IOP monitoring is enhancing early disease detection. For instance, in March 2024, the National Eye Institute granted USD 6.7 Million to Purdue University to develop innovative smart contact lens tonometers. These patent-pending devices, utilizing "StickTronics," will continuously monitor intraocular pressure (IOP) and deliver therapeutic drugs, aiding in the management of chronic eye conditions like glaucoma. Besides this, the shift toward virtual eye screenings and AI-powered diagnostics is expected to bridge the gap in glaucoma management, ensuring timely intervention and reducing the risk of vision impairment.
Indirect stand as the largest type in 2024. The dominance of the indirect segment within the tonometer market is largely attributed to the increasing prevalence of glaucoma and the growing need for efficient and patient-friendly intraocular pressure (IOP) measurement. Indirect tonometers, particularly rebound tonometers, offer advantages such as reduced patient discomfort and a lower risk of corneal damage, making them suitable for widespread screening, including in pediatric and geriatric populations. Additionally, advancements in technology have improved the accuracy and reliability of indirect tonometers, further driving their adoption in clinical settings.
Applanation tonometry leads the market with around 51.4% of market share in 2024. Applanation tonometry's dominance in the tonometer market stems from its established reliability and accuracy in measuring intraocular pressure (IOP), a crucial factor in glaucoma diagnosis. The Goldmann applanation tonometer, in particular, is considered the "gold standard" for IOP measurement, contributing to its widespread use in clinical settings. This technique's ability to provide consistent and precise readings has solidified its position, even with the emergence of newer technologies. Additionally, established clinical practices and widespread familiarity among ophthalmologists reinforce the continued preference for applanation tonometers.
Handheld leads the market with around 72.2% of market share in 2024. The dominance of the handheld tonometer segment in the market stems from its enhanced portability and convenience. These devices enable healthcare professionals to conduct intraocular pressure (IOP) measurements in various settings, beyond traditional clinic environments. This flexibility is crucial for screening programs, home healthcare, and situations where patient mobility is limited. Furthermore, advancements in technology have led to increased accuracy and ease of use in handheld tonometers, making them a preferred choice for both practitioners and patients. The growing prevalence of glaucoma and the rising geriatric population, who require frequent IOP monitoring, further fuel the demand for these portable devices
Ophthalmic centers lead the market with around 62.0% of market share in 2024. Ophthalmic centers dominate the tonometer market due to their specialized focus on eye care. These centers are primary locations for diagnosing and managing conditions like glaucoma, which necessitates frequent intraocular pressure (IOP) measurements. Therefore, they require a consistent and high volume of tonometer usage. Ophthalmic centers conduct routine screenings and detailed examinations, driving demand for both desktop and handheld tonometers. Additionally, these facilities often invest in advanced tonometer technology to ensure accurate and reliable IOP readings, contributing to their significant market share. The increase in eye related diseases, and an aging population, also increases the amount of patients visiting these centers.
In 2024, North America accounted for the largest market share of over 39.6%. North America's dominance in the tonometer market stems from a confluence of factors. Robust healthcare infrastructure, coupled with a high prevalence of eye disorders like glaucoma, drives significant demand. For instance, the CDC reports glaucoma affects about 3 million Americans and is the second leading cause of global blindness. Open-angle glaucoma, the most common type, often has no early symptoms, leaving 50% of those affected unaware, heightening the need for diagnostic tools like tonometer. The region's advanced medical technology adoption, particularly in the United States, fosters innovation and the development of sophisticated tonometers. Furthermore, the presence of key industry players and established healthcare centers reinforces market leadership. A large geriatric population, which is more prone to glaucoma, also contributes to the high demand for tonometers. All of these points add up to North America being the leading market for tonometers.
United States Tonometer Market Analysis
In 2024, the United States held 91.4% of the market share in North America. The growing adoption of tonometer due to the rising prevalence of eye-related disorders is a significant market driver. According to reports, about 1.8 Million Americans aged 40 years and older are affected by AMD. With increasing cases of glaucoma and other ocular conditions, the demand for tonometer devices has risen across various healthcare settings. Regular eye screenings have become crucial as early detection of eye-related disorders help in effective treatment. The rising awareness about eye health, along with advancements in diagnostic technologies, are further fueling the adoption of tonometer. Additionally, improved healthcare infrastructure and accessibility to ophthalmic care have supported market expansion. The integration of digital tonometer devices in hospitals and clinics has also contributed to market growth. Increased healthcare expenditure and government initiatives promoting eye health screenings have encouraged the use of tonometer across different age groups. The focus on patient-centric care, coupled with ongoing innovations in non-contact tonometer devices, has led to wider acceptance in medical facilities. The expanding network of optometrists and ophthalmologists further supports the growing tonometer adoption due to growing eye-related disorders.
Asia Pacific Tonometer Market Analysis
The escalating prevalence of glaucoma, projected to impact 27.8 million additional people in Asia by 2040, primarily in India and China, is fueling substantial tonometer demand. Rapid urbanization and lifestyle shifts increase glaucoma incidence, driving routine eye screenings. Enhanced healthcare infrastructure expands tonometer accessibility in facilities, while governmental initiatives promote early ocular disease detection. The growing number of eye care professionals further broadens access to advanced tonometer technologies. The need for convenient monitoring encourages the adoption of portable, user-friendly home tonometers. Continuous R&D efforts are yielding innovative tonometers with improved accuracy and efficiency, crucial for effective glaucoma management.
Europe Tonometer Market Analysis
The expanding elderly population is a primary catalyst for tonometer market growth, as age significantly elevates the risk of ocular diseases. WHO data highlights the European Region's aging trend, with projections of 300 million individuals aged 60+ by 2050. This demographic shift intensifies demand for tonometers, crucial for diagnosing conditions like glaucoma. Geriatric care facilities are increasingly equipped with these devices, enhancing early detection. Continued research fuels innovation in tonometer technology, resulting in more accurate and user-friendly devices, such as automated and digital models. This technological advancement allows for more efficient screening. Moreover, government investments in elderly healthcare, combined with heightened public awareness about proactive eye health, further propel tonometer adoption. Integrating tonometers into comprehensive ophthalmic care ensures timely intervention, preserving vision in the aging population.
Latin America Tonometer Market Analysis
The surging diabetic population in Latin America is significantly fueling tonometer device demand. With 31.6 million diabetics in 2019, projections indicate a rise to 40.2 million by 2030, and 49.1 million by 2045. This growth directly correlates with increased diabetic retinopathy and glaucoma cases, necessitating routine intraocular pressure monitoring. Healthcare providers are integrating tonometers into standard diabetes care, enhancing early detection. Expanding healthcare initiatives are improving tonometer accessibility in hospitals and diagnostic centers. The diabetic surge is also driving research into advanced tonometer technologies for improved diagnostic precision. Public health campaigns are crucial, educating individuals about the critical link between diabetes and eye health, thereby promoting proactive eye care.
Middle East and Africa Tonometer Market Analysis
The tonometer market is expanding due to the rapid growth of healthcare facilities, as evidenced by Dubai's sector, which saw a surge to 4,482 private medical facilities and 55,208 licensed professionals by 2022, with further growth projected. Increased healthcare infrastructure investments are enhancing access to advanced tonometers. Additionally, rising health awareness campaigns emphasizing preventive eye care, coupled with expanding ophthalmic diagnostic services, are driving routine tonometer screenings. This heightened focus on early detection is significantly contributing to market growth.
The tonometer market's competitive landscape is characterized by a mix of established medical device manufacturers and specialized ophthalmic technology companies. Innovation is a key driver, with firms focusing on developing more portable, user-friendly, and accurate tonometers. Competition centers on technological advancements, such as non-contact and rebound tonometry, and integrated devices with digital capabilities. Market players strive to offer comprehensive solutions, including data management and connectivity, to enhance clinical workflows. Price competition exists, particularly for basic models, while premium devices with advanced features command higher prices. Strategic partnerships and acquisitions are also common tactics to expand product portfolios and market reach. Regulatory approvals and adherence to stringent quality standards are critical for market entry and sustained growth.